CBB, agreed. It would be nice to see them get over the 10% mark, at least. As it is, AMRN is one of Sarissa's smallest investments, and fairly insignificant to their overall portfolio (just over 3%). They just sold $180M in ALKS shares. I think them spending a few million on an additional AMRN purchase was more PR/window-dressing than anything.
It certainly doesn't hurt, but I don't think this will move the needle in the slightest.